The mass spectrometry data thus agree with our earlier studies, showing that primary cells from patients with hematological malignancies signal almost exclusively through TRAIL-R1 (MacFarlane et al., 2005a, 2005b). This evidence concerns the gene TNFRSF10A and hematologic disorder.